Evaluation of Antidepressant Potential of Hydrastis canadensis in Mice

Sadia Batool; Haneen Saeed; Sarah Yehya; Rasha Ali; Afia Mofreh; Hanaa Saeed

doi:10.3889/oamjms.2020.4903

Authors

Sadia Batool Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Kingdom of Saudi Arabia
Haneen Saeed Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Kingdom of Saudi Arabia
Sarah Yehya Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Kingdom of Saudi Arabia
Rasha Ali
Afia Mofreh Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Kingdom of Saudi Arabia
Hanaa Saeed Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Kingdom of Saudi Arabia

DOI:

https://doi.org/10.3889/oamjms.2020.4903

Keywords:

Hydrastis canadensis, Goldenseal, Depression, Fluoxetine, Mice

Abstract

BACKGROUND: Depression is one of the most common chronic psychological disorders around the world presenting with many interpersonal and social problems. Common antidepressants have various adverse effects and are not safe for long-term therapy. Alternative safer remedies are under investigation with a focus on herbal therapies. Hydrastis canadensis is a perennial herb, rich in many phytoconstituents ranging from amino acids to alkaloids, flavonoids, and steroids. It is also widely used in Chinese folklore tradition for mood elevating effects; however, this has not been scientifically proven.

AIM: This study is thus aimed at evaluating antidepressant potential of this plant.

MATERIALS AND METHODS: Ethanolic extract of dried root of plant was prepared by maceration technique and was subjected to phytochemical screening. Mice were divided into four groups (n = 5). Tween 80, 2 ml (negative control), fluoxetine 10 mg/kg (positive control), and extracts at 150 mg/kg and 250 mg/kg were administered by intraperitoneal route to mice in their respective groups. The locomotor activity was assessed for 5 min using actimeter at 0, 30, and 60 min for each animal. Increase in locomotion was an index of antidepressant effect. The mean value of each group was calculated and results were compared by one-way ANOVA. p < 0.05 was considered statistically significant.

RESULTS: Phytochemical screening yielded positive results for alkaloids and saponins. Locomotion was increased in groups treated with fluoxetine and extract at 150 mg and 250 mg/kg dose when compared to negative control (1% – Tween 80). This was an index of antidepressant effect. However, the results were statistically significant (p < 0.05) for fluoxetine and extract treated groups at 250 mg/kg. Fluoxetine demonstrated the highest antidepressant effect.

CONCLUSION: This study has demonstrated the antidepressant potential of Hydrastis canadensis ethanolic extract. Further studies are required to validate these findings on other experimental models. The specific active constituent and effects at cellular level need to be evaluated.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(9):655-79. PMid:21896369

Azzopardi LM. Mood disorders. In: Lecture Notes in Pharmacy Practice. London: Pharmaceutical Press; 2010. p. 157-8.

Fekadu N, Shibeshi W, Engidawork E. Major depressive disorder: Pathophysiology and clinical management. J Depress Anxiety. 2016;6:255. https://doi.org/10.4172/2167-1044.1000255

Fava M. Prospective studies of adverse events related to antidepressant discontinuation. J Clin Psychiatry. 2006;67(4):14-21. PMid:16683858

Ferguson JM. SSRI antidepressant medications: Adverse effects and tolerability. Prim Care Companion J Clin Psychiatry. 2001;3(1):22-7. https://doi.org/10.4088/pcc.v03n0105 PMid:15014625

Furukawa TA, McGuire H, Barbui C. Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: Systematic review. BMJ. 2002;325(7371):991. https://doi.org/10.1136/bmj.325.7371.991 PMid:12411354

Agius M, Hannah B. Antidepressants in use in clinical practice. Psychiatr Danubina. 2017;29(3):667-71.

Hobbs C. Golden seal in early American medical botany. Pharm Hist. 1990;32(2):79-82. PMid:11622733

Asmi S, Lakshmi T. Therapeutic aspects of goldenseal. Int Res J Pharm. 2013;4(9):41-3.

Kulkarni SK, Dhir A. Berberine: A plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res. 2010;24(3):317-24. https://doi.org/10.1002/ptr.2968 PMid:19998323

Kumar A, Ekavali E, Chopra K, Mukherjee M, Pottabathini R, Dhull DK. Current knowledge and pharmacological profile of berberine: An update. Eur J Pharmacol. 2015;761:288-97. https://doi.org/10.1016/j.ejphar.2015.05.068 PMid:26092760

Scazzocchio F, Cometa MF, Tomassini L, Palmery M. Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. Planta Med. 2001;67(6):561-4. PMid:11509983

Rehman J, Dillow JM, Carter SM, Chou J, Le B, Maisel AS. Increased production of antigen-specific immunoglobulins G and M following in vivo treatment with the medicinal plants Echinacea angustifolia and Hydrastis canadensis. Immunol Lett. 1999;68(2-3):391-5. https://doi.org/10.1016/ s0165-2478(99)00085-1 PMid:10424448

Li Z, Geng YN, Jiang JD, Kong WJ. Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid Based Complement Alternat Med. 2014;2014:289264. PMid:24669227

Saha SK, Sikdar S, Mukherjee A, Bhadra K, Boujedaini N, Khuda-Bukhsh AR. Ethanolic extract of the goldenseal, Hydrastis canadensis, has demonstrable chemopreventive effects on HeLa cells in vitro: Drug-DNA interaction with calf thymus DNA as target. Environ Toxicol Pharm. 2013;36(1):202- 14. https://doi.org/10.1016/j.etap.2013.03.023 PMid:23628949

Hong DD, Hien HM, Lan HT. Studies on the analgesic and anti-inflammatory activities of Sargassum swartzii Agardh (phaeophyta) and Ulva reticulata Forsskal (Chlorophyta) in experiment animal models. Afr J Biotechnol. 2011;10(12):2308-14.

Trease G, Evans SM. Pharmacognosy. 15th ed. London: Bailer Tindal; 2002. p. 23-67.

Deepika B, Sweta K, Yadav J, et al. CNS stimulant activity of aqueous extract of roots of Boerhavia diffusa in mice. Indian J Pharmacol. 2013;45(3):264-9.

Upton R. Goldenseal root Hydrastis canadensis: Standards of Analysis, Quality Control, and Therapeutics. California: American Herbal Pharmacopoeia; 2001.

Roy S, Jyoti S, Rahman A. Anti-carcinogenic potentials of a plant extract (Hydrastis canadensis): Evidence from in vivo studies in mice (Mus musculus). Asian Pac J Can Prev. 2010;11(2):545-51. PMid:20843149

Bukhari IA, Dar A. Behavioral profile of Hypericum perforatum (St. John’s Wort) extract. A comparison with standard antidepressants in animal models of depression. Eur Rev Med Pharmacol Sci. 2013;17(8):1082-9. PMid:23661522

Lee B, Sur B, Yeom M, Shim I, Lee H, Hahm DH. Effect of berberine on depression-and anxiety-like behaviors and activation of the noradrenergic system induced by development of morphine dependence in Rats. Korean J Physiol Pharmacol. 2012;16:379-86. https://doi.org/10.4196/kjpp.2012.16.6.379 PMid:23269899

Wang K, Feng X, Chai L, Cao S, Qiu F. The metabolism of berberine and its contribution to the pharmacological effects. Drug Metab Rev. 2017;49:1-19. PMid:28290706

Farias FM, Passos CS, Arbo MD, Barros DM, Gottfried C, Steffen VM, et al. Strictosidinic acid, isolated from Psychotria myriantha Mull. Arg. (Rubiaceae), decreases serotonin levels in rat hippocampus. Fitoterapia. 2012;83(6):1138-43. https://doi. org/10.1016/j.fitote.2012.04.013 PMid:22546150

Wang X, Wang R, Xing D, Su H, Ma C, Ding Y, et al. Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of coptidis rhizoma extract. Life Sci. 2005;77(24):3058-67. https://doi.org/10.1016/j. lfs.2005.02.033 PMid:15996686

Knoll J. History of deprenyl-the first selective inhibitor of monoamine oxidase Type B. Vopr Med Khim. 1997;43(6):482-93. PMid:9503565

Wouters J. Structural aspects of monoamine oxidase and its reversible inhibition. Curr Med Chem. 1998;5(2):137-62. PMid:9481038

Guangting H, Leilei W, Liu M, Yuanming Z. Component analysis and micro fiber arrangement of Apocynum venetum fibers: The MS and AFM study. Carbohydr Polym. 2008;72(4):652-6. https://doi.org/10.1016/j.carbpol.2007.10.002

Jacobsen JP, Medvedev IO, Caron MG. The 5-HT deficiency theory of depression: Perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase knock in mouse. Philos Trans R Soc Lond B Biol Sci. 2012;367(1601):2444-59. https://doi.org/10.1098/rstb.2012.0109 PMid:22826344

Hamilton MS, Opler LA. Akathisia, suicidality and fluoxetine. J Clin Psychiatry 1992;53(11):401-6. PMid:1364815